Strategy
DNage aims at becoming a global leader in ageing related drug development. We are now in the second stage of the company’s development, which is focussed on performing studies in humans with our lead products and building a sustainable product pipeline. Our products have applications in several markets including pharmaceuticals, nutraceuticals and cosmetics but we will focus on the commercialisation of our products for pharmaceutical and nutritional applications.
DNage has developed an attractive, dual business strategy providing:
-
Early revenues through selective partnerships
-
Value creation through our in-house drug development activities
We will provide our partners with a unique technology platform, allowing the development of innovative proprietary products based on a new mechanism of action.
In order to further develop our product portfolio we will be actively looking for strategic alliances with top-tier academic and industrial parties. DNage will be looking for specific expertise and know-how, for example in the fields of osteoporosis, neurodegenerative and cardiovascular disorders.
DNage is also actively looking for compounds or products with:
Proprietary scavenger/anti-oxidant characteristics or activities or other activities affecting DNA damage or genome stability.
Second medical use products, approved drugs with similar characteristics
If you would like to out-license or partner such products, please contact Gerben Zondag (g.zondag@dnage.nl) for further information.